ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0759

Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis

Yogan Kisten1, Alexandra Circiumaru1, Malena Loberg-Haarhaus2, Nancy Vivar2, Aleksandra Antovic3, Hamed Rezaei2, Erik Af Klint1, Aase Hensvold1 and Anca Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 2Rheumatology clinic, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Center for Rheumatology, Academic Specialist Center, Stockholm Health Region, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden

Meeting: ACR Convergence 2020

Keywords: Biomarkers, Imaging, rheumatoid arthritis, risk assessment, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Ultrasound (US) imaging biomarkers in the context of Anti-Citrullinated Protein Antibody (ACPA) autoimmunity might play an important role in the very early detection of Rheumatoid Arthritis (RA).

Methods: Individuals with musculoskeletal complaints suspicious for rheumatic disease, and having a positive anti-CCP2 test were referred to the Rheumatology Unit. Sixty eight joint counts as well as hands, feet and any symptomatic joints by US examination were performed. US were scored for synovial hypertrophy (SH) and Doppler activity according to EULAR-OMERACT definitions. Individuals not having arthritis defined by clinical examination and ultrasound were included in the RISK RA prospective cohort. Finger and wrist tendons were examined for any signs of tenosynovitis, including evaluations between joints for bursitis. The associations of US biomarkers with arthritis development was tested (comparing proportions) using Chi-Squared or Fisher’s exact tests.

Results: 288 individuals were included in the RISK RA study from year 2014 to October 2019 (79% female, 35% RF positive, median age 48 yrs: IQR: 36-58). Within a median of 38 months (IQR: 1-72) since recruitment, 28% (84/288) progressed to arthritis.

At any scan done prior to diagnosis (either inclusion or follow-up visits), two thirds (193/288) of all individuals lacked any signs of US changes with only 16% (31/193) of them developing arthritis. One third (95/288) of all individuals had at least one type of US change (tenosynovitis, synovial hypertrophy without Doppler and/or bursitis) and 56% (53/95) of them developed arthritis. A majority, 64% (61/95), of individuals with any US changes had only one type of US change.

Tenosynovitis was detected in 22% (64/288) of all individuals, more frequently in those developing arthritis (44%, 37/84) as compared to those not developing arthritis (13%, 27/204), p< 0.0001. The extensor-carpi-ulnaris wrist tendons were mostly affected. Synovial hypertrophy (grade 1 or 2) was detected in 11% (32/288) of all individuals, more frequently noted among those developing (21%,18/84) as compared to those not developing arthritis (7%,14/204), p< 0.0001. The MCP joints were mostly affected. Bursitis between MTP joints were detected in 9% (25/288) of all individuals, more frequently among those developing (13%, 11/84) as compared to those not developing arthritis (7%, 14/204), p=0.09.

Conclusion: Tenosynovitis, synovial hypertrophy and bursitis are useful ultrasound biomarkers for predicting arthritis development in a population at-risk for RA.


Disclosure: Y. Kisten, None; A. Circiumaru, None; M. Loberg-Haarhaus, None; N. Vivar, None; A. Antovic, None; H. Rezaei, None; E. Af Klint, None; A. Hensvold, None; A. Catrina, None.

To cite this abstract in AMA style:

Kisten Y, Circiumaru A, Loberg-Haarhaus M, Vivar N, Antovic A, Rezaei H, Af Klint E, Hensvold A, Catrina A. Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/presence-of-ultrasound-imaging-biomarkers-are-good-predictors-of-arthritis-development-in-a-population-at-risk-for-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-ultrasound-imaging-biomarkers-are-good-predictors-of-arthritis-development-in-a-population-at-risk-for-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology